Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 83 of 178 for:    LENALIDOMIDE AND Leukemia

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00738829
Recruitment Status : Completed
First Posted : August 21, 2008
Last Update Posted : August 30, 2013
Sponsor:
Collaborators:
Celgene Corporation
Roche Pharma AG
Information provided by (Responsible Party):
Arbeitsgemeinschaft medikamentoese Tumortherapie